Chromatin modification and muscle differentiation

Expert Opinion on Therapeutic Targets

Volumn 10, Issue 6, 2006, Pages 923-934

  Yahi, Hakima ^a   Philipot, Ophélie ^a   Guasconi, Valentina ^a   Fritsch, Lauriane ^a   Ait Si Ali, Slimane ^a  

^a CNRS   (France)

Author keywords

Chromatin remodelling; Differentiation; Skeletal muscle

Indexed keywords

HELIX LOOP HELIX PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; TRANSCRIPTION FACTOR;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DUCHENNE MUSCULAR DYSTROPHY; EPIGENETICS; GENE EXPRESSION; HUMAN; MESODERM; MOLECULAR MECHANICS; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; MYOTONIC DYSTROPHY; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SKELETAL MUSCLE; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CHROMATIN; HUMANS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL;

EID: 33751392976     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.10.6.923     Document Type: Review

References (99)

1. BUCKINGHAM M: Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. (2001) 11(4):440-448.
2. CHRIST B, ORDAHL CP: Early stages of chick somite development. Anat. Embryol. (Berl) (1995) 191(5):381-396.
3. BUFFINGER N, STOCKDALE FE: Myogenic specification in somites: induction by axial structures. Development (1994) 120(6):1443-1452.
4. MUNSTERBERG AE, KITAJEWSKI J, BUMCROT DA, MCMAHON AP, LASSAR AB: Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes Dev. (1995) 9(23):2911-2922.
5. MUNSTERBERG AE, LASSAR AB: Combinatorial signals from the neural tube, floor plate and notochord induce myogenic bHLH gene expression in the somite. Development (1995) 121(3):651-660.
6. BORYCKI AG, BRUNK B, TAJBAKHSH S et al.: Sonic hedgehog controls epaxial muscle determination through Myf5 activation. Development (1999) 126(18):4053-4063.
7. MARCELLE C, STARK MR, BRONNER-FRASER M: Coordinate actions of BMPs, Wnts, Shh and noggin mediate patterning of the dorsal somite. Development (1997) 124(20):3955-3963.
8. TAPSCOTT SJ, DAVIS RL, THAYER MJ et al.: MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science (1988) 242(4877):405-411.
9. RHODES SJ, KONIECZNY SF: Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. (1989) 3(12B):2050-2061.
10. TAJBAKHSH S, ROCANCOURT D, COSSU G, BUCKINGHAM M: Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell (1997) 89(1):127-138.
11. KASSAR-DUCHOSSOY L, GAYRAUD-MOREL B, GOMES D et al.: Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature (2004) 431(7007):466-471.
12. RELAIX F, ROCANCOURT D, MANSOURI A, BUCKINGHAM M: Divergent functions of murine Pax3 and Pax7 in limb muscle development. Genes Dev. (2004) 18(9):1088-1105.
13. MENNERICH D, SCHAFER K, BRAUN T: Pax-3 is necessary but not sufficient for lbx1 expression in myogenic precursor cells of the limb. Mech. Dev. (1998) 73(2):147-158.
14. YUN K, WOLD B: Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. (1996) 8(6):877-889.
15. MOLKENTIN JD, OLSON EN: Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. (1996) 6(4):445-453.
16. ARNOLD HH, BRAUN T: Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. Int. J. Dev. Biol. (1996) 40(1):345-353.
17. TAJBAKHSH S, ROCANCOURT D, BUCKINGHAM M: Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature (1996) 384(6606):266-270.
18. KABLAR B, KRASTEL K, YING C et al.: Myogenic determination occurs independently in somites and limb buds. Dev. Biol. (1999) 206(2):219-231.
19. RUDNICKI MA, SCHNEGELSBERG PN, STEAD RH et al.: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell (1993) 75(7):1351-1359.
20. KAUL A, KOSTER M, NEUHAUS H, BRAUN T: Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Cell (2000) 102(1):17-19.
21. KABLAR B, KRASTEL K, TAJBAKHSH S, RUDNICKI MA: Myf5 and MyoD activation define independent myogenic compartments during embryonic development. Dev. Biol. (2003) 258(2):307-318.
22. TAJBAKHSH S, BOBER E, BABINET C et al.: Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev. Dyn. (1996) 206(3):291-300.
23. RUDNICKI MA, BRAUN T, HINUMA S, JAENISCH R: Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell (1992) 71(3):383-390.
24. SUMMERBELL D, HALAI C, RIGBY PW: Expression of the myogenic regulatory factor Mrf4 precedes or is contemporaneous with that of Myf5 in the somitic bud. Mech. Dev. (2002) 117(1-2):331-335.
25. TAJBAKHSH S: The genetics of murine skeletal muscle biogenesis. Results Probl. Cell Differ. (2002) 38:61-79.
26. CHAKRABORTY T, BRENNAN TJ, LI L, EDMONDSON D, OLSON EN: Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding. Mol. Cell. Biol. (1991) 11(7):3633-3641.
27. LASSAR AB, DAVIS RL, WRIGHT WE et al.: Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 66(2):305-315.
28. MURRE C, MCCAW PS, VAESSIN H et al.: Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 58(3):537-544.
29. ARNOLD HH, WINTER B: Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. (1998) 8(5):539-544.
30. LASSAR A, MUNSTERBERG A: Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr. Opin. Cell Biol. (1994) 6(3):432-442.
31. BRENNAN TJ, OLSON EN: Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev. (1990) 4(4):582-595.
32. FRENCH BA, CHOW KL, OLSON EN, SCHWARTZ RJ: Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter. Mol. Cell. Biol. (1991) 11(5):2439-2450.
33. BIESIADA E, HAMAMORI Y, KEDES L, SARTORELLI V: Myogenic basic helix-loop-helix proteins and Sp 1 interact as components of a multiprotein transcriptional complex required for activity of the human cardiac alpha-actin promoter. Mol. Cell. Biol. (1999) 19(4):2577-2584.
34. FORCALES SV, PURI PL: Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression. Semin. Cell Dev. Biol. (2005) 16(4-5):596-611.
35. WEINTRAUB H, TAPSCOTT SJ, DAVIS RL et al.: Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA (1989) 86(14):5434-5438.
36. KOCAEFE YC, ISRAELI D, OZGUC M, DANOS O, GARCIA L: Myogenic program induction in mature fat tissue (with MyoD expression). Exp. Cell Res. (2005) 308(2):300-308.
37. TAPSCOTT SJ: The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development (2005) 132(12):2685-2695.
38. MCKINSEY TA, ZHANG CL, OLSON EN: Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. (2001) 11(5):497-504.
39. BLACK BL, OLSON EN: Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Ann. Rev. Cell Dev. Biol. (1998) 14:167-196.
40. MOLKENTIN JD, LI L, OLSON EN: Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. (1996) 271(29):17199-17204.
41. FICKETT JW: Coordinate positioning of MEF2 and myogenin binding sites. Gene (1996) 172(1):GC19-GC32.
42. BOUR BA, O'BRIEN MA, LOCKWOOD WL et al.: Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. (1995) 9(6):730-741.
43. ORNATSKY OI, ANDREUCCI JJ, MCDERMOTT JC: A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. (1997) 272(52):33271-33278.
44. EDMONDSON DG, CHENG TC, CSERJESI P, CHAKRABORTY T, OLSON EN: Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell Biol. (1992) 12(9):3665-3677.
45. WANG DZ, VALDEZ MR, MCANALLY J, RICHARDSON J, OLSON EN: The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development (2001) 128(22):4623-4633.
46. SKAPEK SX, RHEE J, SPICER DB, LASSAR AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (1995) 267(5200):1022-1024.
47. KITZMANN M, VANDROMME M, SCHAEFFER V et al.: cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol. Cell. Biol. (1999) 19(4):3167-3176.
48. 1-phase degradation of MyoD in muscle cells. Exp. Cell Res. (2000) 259(1):300-307.
49. TINTIGNAC LA, SIRRI V, LEIBOVITCH MP et al.: Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. Mol. Cell. Biol. (2004) 24(4):1809-1821.
50. MAL A, HARTER ML: MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl. Acad. Sci. USA (2003) 100(4):1735-1739.
51. MAL A, STURNIOLO M, SCHILTZ RL, GHOSH MK, HARTER ML: A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. (2001) 20(7):1739-1753.
52. FULCO M, SCHILTZ RL, IEZZI S et al.: Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell (2003) 12(1):51-62.
53. VORONOVA A, BALTIMORE D: Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains. Proc. Natl. Acad. Sci. USA (1990) 87(12):4722-4726.
54. LU J, MCKINSEY TA, ZHANG CL, OLSON EN: Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell (2000) 6(2):233-244.
55. ZHANG CL, MCKINSEY TA, OLSON EN: Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol. Cell. Biol. (2002) 22(20):7302-7312.
56. CARETTI G, DI PADOVA M, MICALES B, LYONS GE, SARTORELLI V: The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. (2004) 18(21):2627-2638.
57. MAIONE R, AMATI P: Interdependence between muscle differentiation and cell-cycle control. Biochim. Biophys. Acta (1997) 1332(1):M19-M30.
58. SORRENTINO V, PEPPERKOK R, DAVIS RL, ANSORGE W, PHILIPSON L: Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature (1990) 345(6278):813-815.
59. MARTELLI F, CENCIARELLI C, SANTARELLI G et al.: MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene (1994) 9(12)3579-3590.
60. CENCIARELLI C, DE SANTA F, PURI PL et al.: Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol. Cell. Biol. (1999) 19(7):5203-5217.
61. MAGENTA A, CENCIARELLI C, DE SANTA F et al.: MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway. Mol. Cell. Biol. (2003) 23(8):2893-2906.
62. 2 phases of the cell cycle. J. Cell Biol. (1996) 135(2):441-456.
63. NOVITCH BG, SPICER DB, KIM PS, CHEUNG WL, LASSAR AB: pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. (1999) 9(9):449-459.
64. PURI PL, IEZZI S, STIEGLER P et al.: Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell (2001) 8(4):885-897.
65. HARBOUR JW, DEAN DC: Chromatin remodeling and Rb activity. Curr. Opin. Cell Biol. (2000) 12(6):685-689.
66. AIT-SI-ALI S, GUASCONI V, FRITSCH L et al.: A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. (2004) 23(3):605-615.
67. BERKES CA, BERGSTROM DA, PENN BH et al.: Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell (2004) 14(4):465-477.
68. DE LA SERNA IL, OHKAWA Y, BERKES CA et al.: MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol. Cell. Biol. (2005) 25(10):3997-4009.
69. PURI PL, SARTORELLI V, YANG XJ et al.: Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell (1997) 1(1):35-45.
70. PURI PL, AVANTAGGIATI ML, BALSANO C et al.: p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. (1997) 16(2):369-383.
71. SARTORELLI V, PURI PL, HAMAMORI Y et al.: Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell (1999) 4(5):725-734.
72. SARTORELLI V, HUANG J, HAMAMORI Y, KEDES L: Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. (1997) 17(2):1010-1026.
73. DILWORTH FJ, SEAVER KJ, FISHBURN AL, HTET SL, TAPSCOTT SJ: In vitro transcription system delineates the distinct roles of the coactivators pCAF and p3OO during MyoD/E47-dependent transactivation. Proc. Natl. Acad. Sci. USA (2004) 101(32):11593-11598.
74. POLESSKAYA A, DUQUET A, NAGUIBNEVA I et al.: CREB-binding protein/p300 activates MyoD by acetylation. J. Biol. Chem. (2000) 275(44):34359-34364.
75. MCKINSEY TA, ZHANG CL, OLSON EN: MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. (2002) 27(1):40-47.
76. ECKNER R, YAO TP, OLDREAD E, LIVINGSTON DM: Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. (1996) 10(19):2478-2490.
77. DE LA SERNA IL, CARLSON KA, IMBALZANO AN: Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat. Genet. (2001) 27(2):187-190.
78. SIMONE C, FORCALES SV, HILL DA et al.: p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat. Genet. (2004) 36(7):738-743.
79. PENN BH, BERGSTROM DA, DILWORTH FJ, BENGAL E, TAPSCOTT SJ: A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev. (2004) 18(19):2348-2353.
80. POLESSKAYA A. NAGUIBNEVA I, FRITSCH L et al.: CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. (2001) 20(23):6816-6825.
81. SCHULTZ E: Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. (1996) 175(1):84-94.
82. MORGAN JE, PARTRIDGE TA: Muscle satellite cells. Int. J. Biochem. Cell Biol. (2003) 35(8):1151-1156.
83. SLOPER JC, PARTRIDGE TA. Skeletal muscle: regeneration and transplantation studies. Br. Med. Bull. (1980) 36(2):153-158.
84. COLLINS CA: Satellite cell self-renewal. Curr. Opin. Pharmacol. (2006) 6(3):301-306.
85. ZAMMIT PS, HESLOP L, HUDON V et al.: Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp. Cell Res. (2002) 281(1):39-49.
86. DUQUET A, POLESSKAYA A. CUVELLIER S et al.: Acetylation is important for MyoD fimcrion in adult mice. EMBO Rep. (2006) Epub ahead of print.
87. MARTIN PT: Role of transcription factors in skeletal muscle and the potential for pharmacological manipulation. Curr. Opin. Pharmacol. (2003) 3(3):300-308.
88. MEGENEY LA, KABLAR B, GARRETT K, ANDERSON JE, RUDNICKI MA: MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. (1996) 10(10):1173-1183.
89. SABOURIN LA, GIRGIS-GABARDO A, SEALE P, ASAKURA A, RUDNICKI MA: Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. (1999) 144(4):631-643.
90. AMACK JD, REAGAN SR, MAHADEVAN MS: Mutant DMPK 3′-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J. Cell Biol. (2002) 159(3):419-429.
91. SATO S, NAKAMURA M, CHO DH et al.: Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy Type 1. Hum. Mol. Genet. (2002) 11(9):1045-1058.
92. IEZZI S, COSSU G, NERVI C, SARTORELLI V, PURI PL: Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc. Natl. Acad. Sci. USA (2002) 99(11):7757-7762.
93. FREY N, MCKINSEY TA, OLSON EN: Decoding calcium signals involved in cardiac growth and function. Nat. Med. (2000) 6(11):1221-1227.
94. GUSTERSON R, BRAR B, FAULKES D et al.: The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade. J. Biol. Chem. (2002) 277(4):2517-2524.
95. AMEYAR-ZAZOUA M, GUASCONI V, AIT-SI-ALI S: siRNA as a route to new cancer therapies. Expert Opin. Biol. Ther. (2005) 5(2):221-224.
96. LANGLOIS MA, BONIFACE C, WANG G et al.: Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells. J. Biol. Chem. (2005) 280(17):16949-16954.
97. NAGUIBNEVA I, AMEYAR-ZAZOUA M, POLESSKAYA A et al.: The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol. (2006) 8(3):278-284.
98. CLOP A, MARCQ F, TAKEDA H et al.: A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat. Genet. (2006) 38(7):813-818.
99. VERDEL A, JIA S, GERBER S et al.: RNAi-mediated targeting of heterochromatin by the RITS complex. Science (2004) 303(5658):672-676.